secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001104659-24-001818
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus Life Sciences provides slide deck with preliminary 2023 sales, but specific data absent from filing excerpt
--------------------------------------------------------------------------------

- Company furnished investor presentation (Exhibit 99.1) covering preliminary 2023 full-year sales and business update.
- Presentation available on company website; no financial figures or guidance changes contained in the truncated exhibit text.
- No other material developments disclosed; uncertainty precludes extraction of concrete numbers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924001818/0001104659-24-001818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924001818/tm242196d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-001818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer